ProgNOP-LBBB: Prognostic Factors in NOP-LBBB After TAVI

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05654792
Collaborator
(none)
230
4.7

Study Details

Study Description

Brief Summary

The goal of this observational study is to find prognostic factors in patients with a new-onset persistent left bundle branch block (NOP-LBBB) after transcatheter aortic valve implantation (TAVI). The main question it aims to answer is:

Are there any factors influencing heart failure or death risk during the year following TAVI in patients with NOP-LBBB ? Participants will have data collection about TAVI procedure and clinical evolution during a one-year follow-up.

Condition or Disease Intervention/Treatment Phase
  • Device: Transcatheter aortic valve implantation

Study Design

Study Type:
Observational
Anticipated Enrollment :
230 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Prognostic Factors in New-Onset Persistent Left Bundle Branch Block After Transcathether Aortic Valve Implantation
Anticipated Study Start Date :
Dec 10, 2022
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
NOP-LBBB

Patients with new-onset persistent left bundle branch block after transcatheter aortic valve implantation

Device: Transcatheter aortic valve implantation
Transcatheter aortic valve implantation in cases of severe aortic stenosis

Outcome Measures

Primary Outcome Measures

  1. Hospitalisation for heart failure or all-cause mortality [At one-year after transcatheter aortic valve implantation]

    Hospitalisation for heart failure or all-cause mortality

Secondary Outcome Measures

  1. Hospitalisation for heart failure [At one-year after transcatheter aortic valve implantation]

    Hospitalisation for heart failure

  2. All-cause mortality [At one-year after transcatheter aortic valve implantation]

    All-cause mortality

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • New-onset persistent left bundle branch block after transcatheter aortic valve implantation
Exclusion Criteria:
  • Pre-existing left bundle branch block

  • Pre-existing right bundle branch block

  • Pre-existing permanent pacemaker

  • Immediate procedural mortality (death ≤72 h post-procedure)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Central Hospital, Nancy, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT05654792
Other Study ID Numbers:
  • 2022PI163
First Posted:
Dec 16, 2022
Last Update Posted:
Dec 16, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Central Hospital, Nancy, France
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 16, 2022